If there are 3 words that have been heard far too often this year, it would be: Supply Chain Disruption. It has affected practically every industry in the marketplace. However, Thomas Medical owns 4 words that aren’t heard enough right now: Made in the USA.

Thomas Medical is committed to production solely in the USA. What does that really mean? Thomas Medical products are 100% produced, assembled, and sterilized right here in the USA. While other medical device manufacturers are enduring long delays in receiving goods, Thomas Medical is sourcing its materials through domestic suppliers.

Manufacturing and Supply Chain Forecasters are predicting these disruptions to continue beyond 2024. Yes, 2024! However, Thomas Medical has and will continue to remain productive, strong, and reliable throughout this supply chain evolution.

Just as there are disruptions in the supply chain, there are people who experience disruptions with planning a family. Infertility affects 10-15% of couples throughout the United States, and 25% of couples in developing countries. Fortunately, there are options available to help couples struggling to fulfill their hopes of having a baby.

Hysterosalpingography (HSG) is the first step taken to investigate and diagnose infertility in women. Thomas Medical makes HSG Catheters which are essential in diagnosing any interruptions in the conception cycle. The HSG Catheter is designed and manufactured to ensure a minimally invasive and consistently effective procedure.

The Thomas Medical Flexible HSG Catheter’s include:

  • Smooth tip reduces risk of trauma
  • Stable placement sheath decreases the need for a tenaculum
  • Concentric balloon secures the internal os to prevent leakage
  • Embedded stylet for cases of stenosis
  • 20% radiopaque material allows the catheter to be seen under x-ray

As many industries continue to wait on products and goods, Thomas Medical has supplies available, here in the United States. Having these tools, such as the HSG Catheter, readily available can allow the diagnostics to be completed and pave the pathway forward to successful fertility.


Supply chain disruptions to continue beyond 2024 – Today’s Medical Developments (todaysmedicaldevelopments.com)

WHO | Global prevalence of infertility, infecundity and childlessness